Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma

One of the most severe and devastating cancer is pancreatic cancer. Pancreatic ductal adenocarcinoma (PDAC) is one of the major pancreatic exocrine cancer with a poor prognosis and growing prevalence. It is the most deadly disease, with an overall five-year survival rate of 6% to 10%. According to v...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Gitika, Kumar, Raj, Kim, Saet-Byul, Lee, Sang-Yeob, Lee, Sung-Lim, Rho, Gyu-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916947/
https://www.ncbi.nlm.nih.gov/pubmed/33670230
http://dx.doi.org/10.3390/biomedicines9020178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916947/
https://www.ncbi.nlm.nih.gov/pubmed/33670230
http://dx.doi.org/10.3390/biomedicines9020178

Ejemplares similares